Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that its management team will visit Israel to meet with high-tech medical companies and pursue further discussions with its long-term partner, WideMed Ltd., to broaden cooperation opportunities. The trip is scheduled from October 21, 2013 to October 25, 2013.

Dehaier provides all-in-one solutions for the diagnosis, evaluation and treatment of obstructive sleep apnea ("OSA"). Based on support from WideMed, Dehaier has developed a new watch-sized device, which can be integrated into WideMed's Morpheus Ox platform. By collecting and recording physiological data from patients who wear the watch-sized device at home, the advanced automatic sleep scoring software generates an accurate and reliable sleep study diagnosis, including Apnea Hypopnea Index ("AHI"), sleep/wake time, and Cheyne-Stokes breathing patterns. The new system is a comprehensive platform that manages a cost-effective sleep services operation, including patient electronic medical records, cardiac and sleep diagnostics outcomes and complete workflow management. The web-based automatic scoring and data management facilitates operational efficiency and maximizes growth potential by giving users valuable and timely clinical information to improve patient treatment.

Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical, commented, "Dehaier is focusing on research and development, SFDA registration and marketing activities of Efficient Sleep Diagnosis System. We deeply believe that the System has great market demand and development potential. By visiting WideMed and discussing further opportunities with them, we hope to reach a long-term agreement and deepen our cooperation. In addition, we believe that other Israeli high-tech medical companies will benefit from learning about Dehaier's innovative and revolutionary medical products."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the potential cooperation talk with WideMed. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CONTACT: Dehaier Medical Systems Limited
         Surie Liu
         +86 10-5166-0080
         lius@dehaier.com.cn
         
         Dehaier Medical Systems Limited
         Tina He
         +86 10-5166-0080
         hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Lianluo Smart Charts.
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lianluo Smart Charts.